ArticleBreast cancer research and treatment2025

Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancer.

Sara Nezirevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.